2 results
Prazosin for the treatment of Obsessive Compulsive Disorder:
An open label, fixed dose add-on study.
To determine whether the addition of the *1 adrenoreceptor antagonist prazosin to SSRI is useful for patients with OCD who do not respond to SRI monotherapy.
Not approvedWill not start
The primary objectives of this study are to assess the performance of the Birmingham Hip Resurfacing in young active men with large femoral heads as measured with the Oxford Hip Score (OHS) and to evaluate the safety of this device as assessed by…